Disease/Infection News

RSS

Combination therapy shows promise for transplanting HCV-infected organs

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe.

8 Nov 2019

Scientists discover role for vitamin D in melanoma

A new study published in Cancer Research suggests that high levels of vitamin D may reduce the aggressive nature of melanoma cells and improve survival rates.

8 Nov 2019

New vaccine strategy shows promise against HIV

A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine strategy--an approach that may also work in protecting people from an array of other deadly infectious diseases.

7 Nov 2019

High hepatitis C rates in Ohio linked to opioid misuse

In an effort to further measure the opioid epidemic's impact in Ohio, the Ohio Alliance for Innovation in Population Health studied hepatitis C rates within the state and discovered consistently high rates in the southern Appalachia region over a five-year period.

7 Nov 2019

New strain of HIV discovered and sequenced

Researchers have for the first time in twenty years come upon a new strain of HIV or Human Immunodeficiency Virus. This strain is a part of the Group M type of HIV-1. HIV-1 is the causative agent of worldwide HIV infections.

7 Nov 2019

New model could predict response of HIV-infected individuals to cancer immunotherapy

A group of researchers at UPF and the Marchuk Institute of Numerical Mathematics in Moscow, Russia, have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

7 Nov 2019

Researchers make new discovery about how exercise protects against cardiovascular disease

A study has identified a molecular link between exercise and inflammation that help to treat cardiovascular disease.

7 Nov 2019

HIV-1 virus characteristics can predict treatment efficacy with specific antibody treatment

Current HIV-1 therapies have been proven to be highly effective in slowing the progression of the virus in the body with only minimal side effects.

6 Nov 2019

New bacteria-killing toxin shows promise to impact superbug infectious diseases

An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.

6 Nov 2019

People increasingly using Reddit to 'diagnose' STDs

A new study reveals that people are sharing images of their genitalia on social media in the hope of getting their sexually transmitted infections (STIs) diagnosed by others. This disturbing news not only points at rise in STIs but also misconceptions and lack of motivation to seek authentic medical advice say researchers. The study was published this week in the latest issue of the Journal of American Medical Association (JAMA).

6 Nov 2019

BfR symposium: Current trends and causes of foodborne disease outbreaks

To make food even safer for humans, experts from scientific institutions, food regulatory authorities and the business community will discuss current developments and strategies at the "Zoonoses and Food Safety" Symposium at the German Federal Institute for Risk Assessment) on 4 and 5 November 2019, in Berlin-Marienfelde. Because some micro-organisms in food can cause health problems.

6 Nov 2019

C. diff puts up a winning fight against hospital disinfectants

The deadly and notoriously stubborn superbug, Clostridioides difficile (C. diff), is putting up a winning fight against hospital-grade disinfectants meant to kill it, according to results of a new study published in the Antimicrobial Agents and Chemotherapy journal of the American Society for Microbiology.

6 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

Medical and socioeconomic factors may hinder employability of people with HIV/AIDS

People living with HIV/AIDS may face discrimination in employers' hiring practices. A study published in the American Journal of Industrial Medicine found that medical and socioeconomic factors may hinder their employment.

6 Nov 2019

HIV increases the prevalence of early menopause, shows study

Thanks to medical advancements, HIV-positive women now have a longer life expectancy, exposing them to numerous midlife health issues such as menopause.

6 Nov 2019

Scientists discover cell protein crucial in preventing viral replication

A research team has discovered a protein without which cells infected by viruses cannot trigger an immune response, leading to 100% mortality with even non-disease-producing strains. The discovery of the new Z-DNA binding protein, or ZBP1, was reported in the journal Frontiers in Microbiology. It could help develop new treatment methods for viruses that target the nervous system such as the Zika or West Nile Encephalitis virus.

6 Nov 2019

Risk assessment model for Ebola transmission accurately predicted Uganda cases

A new risk assessment model for the transmission of Ebola accurately predicted its spread into the Republic of Uganda, according to the Kansas State University researchers who developed it.

5 Nov 2019

Record number of Legionnaires’ cases in 2018 risk lives, cause cleanup headaches

Cases of Legionnaires' disease reached a record high in 2018 — a more than eight-fold increase since the numbers began to climb nearly two decades ago.

5 Nov 2019

Addressing perceived stigma about taking HIV medication can help women at risk

Stigma is an important contributor to the continued HIV epidemic in the United States. While pre-exposure prophylaxis (PrEP) is a medication that can be taken to prevent HIV infection, previous research has shown that a barrier preventing gay, bisexual and other men who have sex with men from using PrEP is fear that partners, family members or community members would believe that those who use PrEP are HIV infected.

4 Nov 2019